Browsing Tag
MoonLake Immunotherapeutics
3 posts
MoonLake Immunotherapeutics says FDA supports existing clinical data for sonelokimab, announces investor day amid strong market reaction
Find out how MoonLake Immunotherapeutics gained FDA support for its sonelokimab data and why investors are watching its 2026 regulatory path closely.
From Phase 3 data to Wall Street panic: Why MoonLake Immunotherapeutics lost 89% overnight
MoonLake’s VELA Phase 3 update rattled investors as MLTX crashed about 89%. Find out what the data really says and how week-52 could change the outlook.
Top gainers on Wall Street : Ferguson, MoonLake, Summit lead the rally
Ferguson, MoonLake, and Summit Therapeutics led U.S. markets on June 3 with gains over 15%. Find out what triggered this breakout rally.